GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Mesa Laboratories Inc (NAS:MLAB) » Definitions » Operating Income

Mesa Laboratories (Mesa Laboratories) Operating Income : $-0.3 Mil (TTM As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Mesa Laboratories Operating Income?

Mesa Laboratories's Operating Income for the three months ended in Dec. 2023 was $-0.1 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.3 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Mesa Laboratories's Operating Income for the three months ended in Dec. 2023 was $-0.1 Mil. Mesa Laboratories's Revenue for the three months ended in Dec. 2023 was $53.5 Mil. Therefore, Mesa Laboratories's Operating Margin % for the quarter that ended in Dec. 2023 was -0.13%.

Warning Sign:

Mesa Laboratories Inc operating margin has been in a 5-year decline. The average rate of decline per year is -39.2%.

Mesa Laboratories's 5-Year average Growth Rate for Operating Margin % was -39.20% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Mesa Laboratories's annualized ROC % for the quarter that ended in Dec. 2023 was -0.05%. Mesa Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 19.69%.


Mesa Laboratories Operating Income Historical Data

The historical data trend for Mesa Laboratories's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesa Laboratories Operating Income Chart

Mesa Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.86 7.92 12.36 4.70 3.32

Mesa Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.40 0.52 -0.66 -0.06 -0.07

Mesa Laboratories Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mesa Laboratories  (NAS:MLAB) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Mesa Laboratories's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-0.268 * ( 1 - -8.74% )/( (578.855 + 686.854)/ 2 )
=-0.2914232/632.8545
=-0.05 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Mesa Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=15.208/( ( (28.574 + max(45.013, 0)) + (31.775 + max(49.083, 0)) )/ 2 )
=15.208/( ( 73.587 + 80.858 )/ 2 )
=15.208/77.2225
=19.69 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(36.34 + 32.879 + 12.826) - (22.716 + 14.316 + 0)
=45.013

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(36.023 + 35.973 + 18.135) - (26.691 + 14.357 + 0)
=49.083

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Mesa Laboratories's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-0.067/53.473
=-0.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Mesa Laboratories Operating Income Related Terms

Thank you for viewing the detailed overview of Mesa Laboratories's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Mesa Laboratories (Mesa Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
12100 West Sixth Avenue, Lakewood, CO, USA, 80228
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.
Executives
Brian David Archbold officer: SVP of Continuous Improvement 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John Bradley Schmieder director C/O MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Gary M Owens officer: COO 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John V Sakys officer: VP Finance, CFO MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Shannon Hall director 1000 ALFRED NOBEL DRIVE, HERCULES CA 94547
Evan Guillemin director 380 LAFAYETTE STREET, SIXTH FLOOR, NEW YORK NY 10003
R Tony Tripeny director ONE RIVERFRONT PLAZA, CORNING NY 14831
Gregory Dinoia officer: SVP Commercial Operations 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Mesa Laboratories Inc /co/ director 12100 W 6TH AVE, LAKEWOOD CO 80228
John James Sullivan officer: VP Sales & Marketing 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David M Kelly director
Shiraz Shabanali Ladiwala director C/O THERMO FISHER SCIENTIFIC INC., 168 THIRD AVENUE, WALTHAM MA 02451
Robert V Dwyer director 12100 W 6TH AVE, LAKEWOOD CO 80228
Jennifer Sadie Alltoft director 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David Brian Perez director 12100 6TH AVENUE, LAKEWOOD CO 80228

Mesa Laboratories (Mesa Laboratories) Headlines